We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Releases Revised De Novo Pathway Guidance

19 August 2014

Medical Device Alert

On August 14, 2014, the U.S. Food and Drug Administration released an updated draft guidance document regarding de novo premarket review applications, De Novo Classification Process (Evaluation of Automatic Class III Designation).

Read More: FDA Releases Revised De Novo Pathway Guidance

The team

Loading data